MTOR and stomatitis: However, despite detailed instructions given to each patient to prevent and treat oral lesions early, 11 episodes of stomatitis [consistent with minor side effects associated with the activity of mammalian target of rapamycin (mTOR) inhibitors]65, , –68 were observed in five patients, and further classified as mild or moderate.